<DOC>
	<DOCNO>NCT01422109</DOCNO>
	<brief_summary>The objective study compare pharmacokinetics single oral administration 2 capsule YH14659 , fixed-dose combination clopidogrel aspirin develop Yuhan Corporation versus co-administration Plavix ( clopidogrel ) Astrix ( aspirin ) healthy male volunteer .</brief_summary>
	<brief_title>Comparative Pharmacokinetics YH14659</brief_title>
	<detailed_description />
	<mesh_term>Acute Coronary Syndrome</mesh_term>
	<mesh_term>Aspirin</mesh_term>
	<mesh_term>Clopidogrel</mesh_term>
	<criteria>The patient legally authorize representative must sign write informed consent , prior procedure , use form approve local Institutional Review Board detail explanation purpose , content , characteristic drug Healthy male volunteer age 20 year 55 year Have standard weight ≤ ±20 % base Broca index* ( Broca index : ideal weight ( kg ) = ( height ( cm ) 100 ) x 0.9 ) Have history neither congenital chronic disease Have history abnormal symptom opinion result physical examination ( medical checkup ) Eligible subject acceptable medical history , physical examination laboratory test , ECG screen period Received drug induce or/and inhibit drug metabolize enzyme barbital within last 28 day prior first administration Shown symptom doubtful acute disease within last 28 day prior first administration Have sign bleed symptom or/and history disease : gum bleeding , hard control hemorrhage , easily suffer bruise , etc . Have disease affect absorption , distribution , metabolism excretion drug : inflammatory bowel disease , gastric ulcer , duodenal ulcer , hepatic disorder , gastrointestinal tract surgery except appendectomy Have know allergy ( except mild allergic rhinitis require treatment ) hypersensitivity drug Have follow abnormal finding diagnosis ; AST ALT &gt; 1.25 time normal upper limit total bilirubin &gt; 1.5 time normal upper limit high PT , aPPT , BT normal range PLT 150,000 350,000 Have drug abuse , excessive caffeine ( &gt; 5 cups/day ) , heavy smoking ( &gt; 10 cigarettes/day ) , continuous alcohol intake ( &gt; 30g/day ) drunk within last 7 day prior first administration Have diet affect absorption , distribution , metabolism excretion drug ( especially grapefruit juice 7 day prior first administration ) Donated blood within 60 day prior first administration Participated clinical trial within 60 day prior first administration Have use drug think affect study principal investigator 10 day prior first administration Subject judge ineligible principal investigator subinvestigator</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>January 2012</verification_date>
	<keyword>YH14659</keyword>
	<keyword>Aspirin</keyword>
	<keyword>Clopidogrel</keyword>
	<keyword>Yuhan</keyword>
</DOC>